The Europe Dry Eye Treatment Devices Market would witness market growth of 6.9% CAGR during the forecast period (2022-2028).
Wetting less than 5 mm, with or without anesthetic, is regarded as diagnostic for dry eyes in this test. A Schirmer II test can be used to detect reflex secretion if Schirmer's test results are abnormal. This test involves irritating the nasal mucosa with a cotton-tipped applicator and then measuring tear production with Whatman #41 filter paper. Wetting less than 15 mm after five minutes is deemed abnormal for this test. The length of time it takes for tears to separate in the eye is measured using a tear breakup time (TBUT) test. A drop of fluorescein can be injected into the cul-de-sac to measure the tear breakup time.
The amount of lysozyme present in tears is determined using a test for tear protein analysis. Lysozyme makes up between 20 and 40% of the total protein in tears. A good correlation between tests is provided by a lactoferrin analysis test. Different ocular dryness states have abnormally high concentrations of the recently found tear molecule Ap4A. Using a simple Schirmer test and a tear sample, this molecule can be measured biochemically.
It is possible to use this method to find the Ap4A concentrations in patients' tears and so assess scientifically if the samples are symptomatic of dry eye. A diagnostic for a dry eye condition called the tear osmolarity test has been suggested. In comparison to corneal and conjunctival staining, tear break-up time, the Schirmer test, and meibomian gland grading, tear osmolarity may be a more accurate way to diagnose and grade the severity of dry eye.
Patients in Europe with dry eye syndrome range in age and gender. Other than a modern lifestyle, factors that are anticipated to drive the dry eye treatment devices market in Europe include an aging population, a rise in health-conscious consumers, an increase in allergies among Europeans, and an increasing prevalence of digital devices, such as tablets and smartphones, which are continuing to increase eye irritation.
The Germany market dominated the Europe Dry Eye Treatment Devices Market by Country in 2021; thereby, achieving a market value of $22.9 million by 2028. The UK market is exhibiting a CAGR of 6.1% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 7.7% during (2022 - 2028).
Based on Technology, the market is segmented into Meibomian Gland Expression (MGX), Broadband light (BBL), Intense Pulsed Light (IPL) and Combination (MGX+IPL). Based on End User, the market is segmented into Ophthalmic Clinics, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Dry Eye Treatment Devices Market will Hit $348.8 Million by 2028, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiBo Medical Group, Sight Sciences, Inc., Lumenis Ltd., ESW Vision SAS, Johnson & Johnson Vision Care, Inc. and Alcon, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Meibomian Gland Expression (MGX)
- Broadband light (BBL)
- Intense Pulsed Light (IPL)
- Combination (MGX+IPL)
By End User
- Ophthalmic Clinics
- Hospitals
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- MiBo Medical Group
- Sight Sciences, Inc.
- Lumenis Ltd.
- ESW Vision SAS
- Johnson & Johnson Vision Care, Inc.
- Alcon, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Dry Eye Treatment Devices Market, by Technology
1.4.2 Europe Dry Eye Treatment Devices Market, by End User
1.4.3 Europe Dry Eye Treatment Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Dry Eye Treatment Devices Market by Technology
3.1 Europe Meibomian Gland Expression (MGX) Market by Country
3.2 Europe Broadband light (BBL) Market by Country
3.3 Europe Intense Pulsed Light (IPL) Market by Country
3.4 Europe Combination (MGX+IPL) Market by Country
Chapter 4. Europe Dry Eye Treatment Devices Market by End-use
4.1 Europe Ophthalmic Clinics Market by Country
4.2 Europe Hospitals Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Dry Eye Treatment Devices Market by Country
5.1 Germany Dry Eye Treatment Devices Market
5.1.1 Germany Dry Eye Treatment Devices Market by Technology
5.1.2 Germany Dry Eye Treatment Devices Market by End-use
5.2 UK Dry Eye Treatment Devices Market
5.2.1 UK Dry Eye Treatment Devices Market by Technology
5.2.2 UK Dry Eye Treatment Devices Market by End-use
5.3 France Dry Eye Treatment Devices Market
5.3.1 France Dry Eye Treatment Devices Market by Technology
5.3.2 France Dry Eye Treatment Devices Market by End-use
5.4 Russia Dry Eye Treatment Devices Market
5.4.1 Russia Dry Eye Treatment Devices Market by Technology
5.4.2 Russia Dry Eye Treatment Devices Market by End-use
5.5 Spain Dry Eye Treatment Devices Market
5.5.1 Spain Dry Eye Treatment Devices Market by Technology
5.5.2 Spain Dry Eye Treatment Devices Market by End-use
5.6 Italy Dry Eye Treatment Devices Market
5.6.1 Italy Dry Eye Treatment Devices Market by Technology
5.6.2 Italy Dry Eye Treatment Devices Market by End-use
5.7 Rest of Europe Dry Eye Treatment Devices Market
5.7.1 Rest of Europe Dry Eye Treatment Devices Market by Technology
5.7.2 Rest of Europe Dry Eye Treatment Devices Market by End-use
Chapter 6. Company Profiles
6.1 Lumenis Ltd.
6.1.1 Company Overview
6.1.2 Recent strategies and developments:
6.1.2.1 Approval:
6.2 Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental &Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 Alcon, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.3.5.2 Acquisitions:
6.4 Sight Sciences, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 MiBo Medical Group
6.5.1 Company Overview
6.6 ESW vision SAS
6.6.1 Company Overview
TABLE 1 Europe Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 2 Europe Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 3 Europe Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 4 Europe Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 5 Europe Meibomian Gland Expression (MGX) Market by Country, 2018 - 2021, USD Thousands
TABLE 6 Europe Meibomian Gland Expression (MGX) Market by Country, 2022 - 2028, USD Thousands
TABLE 7 Europe Broadband light (BBL) Market by Country, 2018 - 2021, USD Thousands
TABLE 8 Europe Broadband light (BBL) Market by Country, 2022 - 2028, USD Thousands
TABLE 9 Europe Intense Pulsed Light (IPL) Market by Country, 2018 - 2021, USD Thousands
TABLE 10 Europe Intense Pulsed Light (IPL) Market by Country, 2022 - 2028, USD Thousands
TABLE 11 Europe Combination (MGX+IPL) Market by Country, 2018 - 2021, USD Thousands
TABLE 12 Europe Combination (MGX+IPL) Market by Country, 2022 - 2028, USD Thousands
TABLE 13 Europe Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 14 Europe Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 15 Europe Ophthalmic Clinics Market by Country, 2018 - 2021, USD Thousands
TABLE 16 Europe Ophthalmic Clinics Market by Country, 2022 - 2028, USD Thousands
TABLE 17 Europe Hospitals Market by Country, 2018 - 2021, USD Thousands
TABLE 18 Europe Hospitals Market by Country, 2022 - 2028, USD Thousands
TABLE 19 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 20 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 21 Europe Dry Eye Treatment Devices Market by Country, 2018 - 2021, USD Thousands
TABLE 22 Europe Dry Eye Treatment Devices Market by Country, 2022 - 2028, USD Thousands
TABLE 23 Germany Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 24 Germany Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 25 Germany Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 26 Germany Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 27 Germany Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 28 Germany Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 29 UK Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 30 UK Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 31 UK Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 32 UK Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 33 UK Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 34 UK Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 35 France Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 36 France Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 37 France Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 38 France Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 39 France Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 40 France Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 41 Russia Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 42 Russia Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 43 Russia Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 44 Russia Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 45 Russia Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 46 Russia Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 47 Spain Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 48 Spain Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 49 Spain Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 50 Spain Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 51 Spain Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 52 Spain Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 53 Italy Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 54 Italy Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 55 Italy Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 56 Italy Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 57 Italy Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 58 Italy Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 59 Rest of Europe Dry Eye Treatment Devices Market, 2018 - 2021, USD Thousands
TABLE 60 Rest of Europe Dry Eye Treatment Devices Market, 2022 - 2028, USD Thousands
TABLE 61 Rest of Europe Dry Eye Treatment Devices Market by Technology, 2018 - 2021, USD Thousands
TABLE 62 Rest of Europe Dry Eye Treatment Devices Market by Technology, 2022 - 2028, USD Thousands
TABLE 63 Rest of Europe Dry Eye Treatment Devices Market by End-use, 2018 - 2021, USD Thousands
TABLE 64 Rest of Europe Dry Eye Treatment Devices Market by End-use, 2022 - 2028, USD Thousands
TABLE 65 key Information – Lumenis Ltd.
TABLE 66 Key information – Johnson & Johnson
TABLE 67 key information – Alcon, Inc.
TABLE 68 Key Information – Sight Sciences, Inc.
TABLE 69 Key Information – MiBo Medical Group
TABLE 70 Key Information – ESW vision SAS
List of Figures
FIG 1 Methodology for the research
FIG 2 SWOT analysis: Johnson & Johnson
FIG 3 Recent strategies and developments: Alcon, Inc.